-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
ARS Pharmaceuticals, Inc. quarterly and annual Depreciation history and change rate from Q1 2020 to 2024.
- ARS Pharmaceuticals, Inc. Depreciation for the quarter ending 31 Mar 2024 was $11,000, a 45% decline year-over-year.
- ARS Pharmaceuticals, Inc. annual Depreciation for 2024 was $79,000, a 8.2% increase from 2023.
- ARS Pharmaceuticals, Inc. annual Depreciation for 2023 was $73,000, a 115% increase from 2022.
- ARS Pharmaceuticals, Inc. annual Depreciation for 2022 was $34,000, a 96% decline from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)